Metadata
Title
Expert publications
Category
general
UUID
3471e061463441c5b6a8216132a07fee
Source URL
https://about.uq.edu.au/experts-publication/1526/4749
Parent URL
https://about.uq.edu.au/experts/1526
Crawl Time
2026-03-11T08:04:39+00:00
Rendered Raw Markdown
# Expert publications

**Source**: https://about.uq.edu.au/experts-publication/1526/4749
**Parent**: https://about.uq.edu.au/experts/1526

[All
(879)](https://about.uq.edu.au/experts-publication/1526/all)
[Book
(2)](https://about.uq.edu.au/experts-publication/1526/4747)
[Journal Article
(794)](https://about.uq.edu.au/experts-publication/1526/4748)
[Other Outputs
(2)](https://about.uq.edu.au/experts-publication/1526/4749)
[Conference Publication
(54)](https://about.uq.edu.au/experts-publication/1526/4751)
[Book Chapter
(27)](https://about.uq.edu.au/experts-publication/1526/4752)

|  |
| --- |
| 2023  Other Outputs TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of nafamostat and camostat mesylate randomised clinical trials Hernández-Mitre, María Patricia, Morpeth, Susan C., Venkatesh, Balasubramanian, Hills, Thomas E., Davis, Joshua, Mahar, Robert K., McPhee, Grace, Jones, Mark, Totterdell, James, Tong, Steven Y. C. and Roberts, Jason A. (2023). TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of nafamostat and camostat mesylate randomised clinical trials. Middletown, DE, United States: INPLASY: International Platform of Registered Systematic Review and Meta-analysis Protocols. doi: 10.37766/inplasy2023.2.0120 [TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of nafamostat and camostat mesylate randomised clinical trials](https://espace.library.uq.edu.au/view/UQ:1f93020) |
| 2008  Other Outputs Beta-lactam antibiotic dosing in critical care units : bolus vs continuous dosing Roberts, Jason (2008). Beta-lactam antibiotic dosing in critical care units : bolus vs continuous dosing. PhD Thesis, School of Medicine, The University of Queensland. doi: 10.14264/174430 [Beta-lactam antibiotic dosing in critical care units : bolus vs continuous dosing](https://espace.library.uq.edu.au/view/UQ:174430) |